|
Post by mannmade on Aug 6, 2018 15:51:12 GMT -5
I for one think while the current situation is obviously not great that is also may not be a dire as some suggest. Consider the following:
1. Mike has emphatically stat d publically mnkd is not going BM
2. Mike has been publically stating they are working on a overall recapitalization plan. My personal sense is that this would get mnkd enough cash for at least a year.
3. Mike has said that he hopes the dilutive portion of the recap plan should be minimal.
4. I am choosing to take mike at his word regarding the above. Why else would they wait so long to announce a cash deal (pipe etc) and let the price slip almost a $1 unless they have a bigger and better way to raise cash?
5. My humble guess is we will likely know by end do 3rd Q
6. Also consider the wildcard of the Carlyle Group and Kent Kresa’s connection. I could point to other speculative items but for now I am looking at this based on what mike has been telling us. And there is only stwo much he can piblically say.
In the meantime consider:
1. that both scripts (new and refills) are growing as well as revenue.
2. TrepT T should be in phase 3 soon.
3. Mexico, Canada and possibly China will likely have term sheets in next six months
4. Revenue from Brazil should begin to hit either 4thQ or 1st Q of next year
5. Pediatrics study is ahead of schedule
6. Dr. K is publishing and meeting with KOL’s
I think the most important thing right now is not to panic and that mnkd needs to make sure the medical community knows without a doubt that mnkd is here to stay! GLTAL’s!!!
|
|
|
Post by #NoMoreNeedles on Aug 6, 2018 16:58:57 GMT -5
They diluted 13M shares around 1.50 a few days ago hitting the ATM
|
|
|
Post by traderdennis on Aug 6, 2018 17:09:14 GMT -5
They diluted 13M shares around 1.50 a few days ago hitting the ATM Huh? Total volume from July 1st thru just before the crash was 30 million shares. During the crash it was 8 millions. So you are saying that 1/2 the volume in July was ATM? ?? During the crash the price cratered quickly below 50. I believe peppy said volume before the crash on Friday was 1.25 million shares. Also it would be in the companies interest to say they used the atm at x dollars per shares to publicize increased cash on hand.
|
|
|
Post by golfeveryday on Aug 6, 2018 17:42:58 GMT -5
I for one think while the current situation is obviously not great that is also may not be a dire as some suggest. Consider the following: 1. Mike has emphatically stat d publically mnkd is not going BM 2. Mike has been publically stating they are working on a overall recapitalization plan. My personal sense is that this would get mnkd enough cash for at least a year. 3. Mike has said that he hopes the dilutive portion of the recap plan should be minimal. 4. I am choosing to take mike at his word regarding the above. Why else would they wait so long to announce a cash deal (pipe etc) and let the price slip almost a $1 unless they have a bigger and better way to raise cash? 5. My humble guess is we will likely know by end do 3rd Q 6. Also consider the wildcard of the Carlyle Group and Kent Kresa’s connection. I could point to other speculative items but for now I am looking at this based on what mike has been telling us. And there is only stwo much he can piblically say. In the meantime consider: 1. that both scripts (new and refills) are growing as well as revenue. 2. TrepT T should be in phase 3 soon. 3. Mexico, Canada and possibly China will likely have term sheets in next six months 4. Revenue from Brazil should begin to hit either 4thQ or 1st Q of next year 5. Pediatrics study is ahead of schedule 6. Dr. K is publishing and meeting with KOL’s I think the most important thing right now is not to panic and that mnkd needs to make sure the medical community knows without a doubt that mnkd is here to stay! GLTAL’s!!! how much is the manufacturing facility worth in Danbury if sold?
|
|
|
Post by mytakeonit on Aug 6, 2018 18:20:22 GMT -5
Not as much as what it's worth when we start ramping up in a few weeks.
|
|
|
Post by cjm18 on Aug 6, 2018 19:33:33 GMT -5
They diluted 13M shares around 1.50 a few days ago hitting the ATM How do you know?
|
|
|
Post by agedhippie on Aug 6, 2018 19:35:26 GMT -5
I for one think while the current situation is obviously not great that is also may not be a dire as some suggest. Consider the following: 1. Mike has emphatically stat d publically mnkd is not going BM 2. Mike has been publically stating they are working on a overall recapitalization plan. My personal sense is that this would get mnkd enough cash for at least a year. 3. Mike has said that he hopes the dilutive portion of the recap plan should be minimal. 4. I am choosing to take mike at his word regarding the above. Why else would they wait so long to announce a cash deal (pipe etc) and let the price slip almost a $1 unless they have a bigger and better way to raise cash? 5. My humble guess is we will likely know by end do 3rd Q 6. Also consider the wildcard of the Carlyle Group and Kent Kresa’s connection. I could point to other speculative items but for now I am looking at this based on what mike has been telling us. And there is only stwo much he can piblically say. In the meantime consider: 1. that both scripts (new and refills) are growing as well as revenue. 2. TrepT T should be in phase 3 soon. 3. Mexico, Canada and possibly China will likely have term sheets in next six months 4. Revenue from Brazil should begin to hit either 4thQ or 1st Q of next year 5. Pediatrics study is ahead of schedule 6. Dr. K is publishing and meeting with KOL’s I think the most important thing right now is not to panic and that mnkd needs to make sure the medical community knows without a doubt that mnkd is here to stay! GLTAL’s!!! Mike's comments are motherhood and apple pie, there is nothing else he could say. He would be negligent if he wasn't working on a recapitalization plan, and obviously he hopes dilution would be kept to a minimum in that recapitalization - but to an extent he is not the master of his own fate given the cash flow. My suspicion was that he expected to get a big bump off the ADA and Russell 3000 listing in June which would have put him in a good position to either do a deal or hit the ATM. That bump never appeared (sadly for me, I had bought Calls against that bump) and he is suddenly left scrabbling. Good funding terms are hard to find when you are cash strapped and have just announced that sales are not going as well as you had expected. I am not panicking at this point (although I had to roll the Calls to a better position), but right now the question is how to raise the case. I have those Calls out a long way so the short term does not bother me as much provided it can be got through with minimal damage.
|
|
|
Post by agedhippie on Aug 6, 2018 19:42:53 GMT -5
how much is the manufacturing facility worth in Danbury if sold? Aside from the Deerfield notes the property also secures the 2013 Milestones Rights Purchase Agreement so it cannot be sold without the creditors consent. That rights agreement lasts until Mannkind have made over $1.5 billion and paid $75 million - although at that point it may not matter
|
|
|
Post by slugworth008 on Aug 6, 2018 21:31:47 GMT -5
I think the most important thing right now is to remain above 1.00 - jmho
|
|
|
Post by morgieporgie on Aug 6, 2018 21:43:30 GMT -5
I for one think while the current situation is obviously not great that is also may not be a dire as some suggest. Consider the following: 1. Mike has emphatically stat d publically mnkd is not going BM 2. Mike has been publically stating they are working on a overall recapitalization plan. My personal sense is that this would get mnkd enough cash for at least a year. 3. Mike has said that he hopes the dilutive portion of the recap plan should be minimal. 4. I am choosing to take mike at his word regarding the above. Why else would they wait so long to announce a cash deal (pipe etc) and let the price slip almost a $1 unless they have a bigger and better way to raise cash? 5. My humble guess is we will likely know by end do 3rd Q 6. Also consider the wildcard of the Carlyle Group and Kent Kresa’s connection. I could point to other speculative items but for now I am looking at this based on what mike has been telling us. And there is only stwo much he can piblically say. In the meantime consider: 1. that both scripts (new and refills) are growing as well as revenue. 2. TrepT T should be in phase 3 soon. 3. Mexico, Canada and possibly China will likely have term sheets in next six months 4. Revenue from Brazil should begin to hit either 4thQ or 1st Q of next year 5. Pediatrics study is ahead of schedule 6. Dr. K is publishing and meeting with KOL’s I think the most important thing right now is not to panic and that mnkd needs to make sure the medical community knows without a doubt that mnkd is here to stay! GLTAL’s!!! Mike's comments are motherhood and apple pie, there is nothing else he could say. He would be negligent if he wasn't working on a recapitalization plan, and obviously he hopes dilution would be kept to a minimum in that recapitalization - but to an extent he is not the master of his own fate given the cash flow. My suspicion was that he expected to get a big bump off the ADA and Russell 3000 listing in June which would have put him in a good position to either do a deal or hit the ATM. That bump never appeared (sadly for me, I had bought Calls against that bump) and he is suddenly left scrabbling. Good funding terms are hard to find when you are cash strapped and have just announced that sales are not going as well as you had expected. I am not panicking at this point (although I had to roll the Calls to a better position), but right now the question is how to raise the case. I have those Calls out a long way so the short term does not bother me as much provided it can be got through with minimal damage. One thing I thought as interesting from the call is that Mike said something along the lines that this will finish up the recapitalization of the company - or something to that effect.
|
|
|
Post by slugworth008 on Aug 6, 2018 22:41:21 GMT -5
Mike's comments are motherhood and apple pie, there is nothing else he could say. He would be negligent if he wasn't working on a recapitalization plan, and obviously he hopes dilution would be kept to a minimum in that recapitalization - but to an extent he is not the master of his own fate given the cash flow. My suspicion was that he expected to get a big bump off the ADA and Russell 3000 listing in June which would have put him in a good position to either do a deal or hit the ATM. That bump never appeared (sadly for me, I had bought Calls against that bump) and he is suddenly left scrabbling. Good funding terms are hard to find when you are cash strapped and have just announced that sales are not going as well as you had expected. I am not panicking at this point (although I had to roll the Calls to a better position), but right now the question is how to raise the case. I have those Calls out a long way so the short term does not bother me as much provided it can be got through with minimal damage. One thing I thought as interesting from the call is that Mike said something along the lines that this will finish up the recapitalization of the company - or something to that effect. Was that recapitalization or recopitulation? (sp)
|
|
|
Post by morgieporgie on Aug 6, 2018 22:48:44 GMT -5
One thing I thought as interesting from the call is that Mike said something along the lines that this will finish up the recapitalization of the company - or something to that effect. Was that recapitalization or recopitulation? (sp) Regurgitation maybe? Who knows at this point.
|
|